Concepedia

Publication | Open Access

Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer

DOIFull Paper Access

109

Citations

17

References

2010

Year

Daphne Tsoi, Miho Inoue, Catherine M. Kelly, Sunil Verma, Kathleen I. Pritchard
The Oncologist

Abstract

The 21-gene assay appears cost-effective from a Canadian health care perspective.

References

YearCitations

Page 1